# A Phase II Trial to Compare Efficacy and Safety of CRT VS Neo-CRT in Patients Who Achieved CCR for Esophageal Cancer

> **NCT02959385** · PHASE2 · UNKNOWN · sponsor: **Tianjin Medical University Cancer Institute and Hospital** · enrollment: 40 (estimated)

## Conditions studied

- Stage II Esophageal Cancer
- Stage III Esophageal Cancer

## Interventions

- **RADIATION:** Definitive Radiochemotherapy
- **PROCEDURE:** Neoadjuvant Radiochemotherapy

## Key facts

- **NCT ID:** NCT02959385
- **Lead sponsor:** Tianjin Medical University Cancer Institute and Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2016-09
- **Primary completion:** 2018-09
- **Final completion:** 2021-09
- **Target enrollment:** 40 (ESTIMATED)
- **Last updated:** 2017-07-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02959385

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02959385, "A Phase II Trial to Compare Efficacy and Safety of CRT VS Neo-CRT in Patients Who Achieved CCR for Esophageal Cancer". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT02959385. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*